Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2007-03-02

Clinical Trial Update: Effect of Lactulose on Minimal Hepatic Encephalopathy and Health-Related Quality of Life [Phase 4]

View source ↗

Summary

Phase 4 clinical trial evaluating the effect of lactulose on minimal hepatic encephalopathy and health-related quality of life has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • LACTULOSE (Lactulose)

Snippet

Sponsor: Post Graduate Institute of Medical Education and Research, Chandigarh | Conditions: Minimal Hepatic Encephalopathy, Hepatic Encephalopathy | Phase 4 | Status: COMPLETED